Literature DB >> 11570610

Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate.

M W Agelink1, R Malessa, B Baumann, T Majewski, F Akila, T Zeit, D Ziegler.   

Abstract

The authors undertook this study to determine the effects of age, gender, and heart rate (HR) on the results of cardiac autonomic function tests for measuring heart rate variability (HRV) in a large sample of healthy subjects (n = 309). Conventional tests (deep breathing, maximum/minimum 30:15 ratio), and a standardized 5-minute resting study, including spectral analysis of HR, were used. The main findings included (1) the indices of all tests, except for the ratio of the low- (LF) to high-frequency (HF) spectral power (LF/HF ratio) and HR itself, are inversely related to age in both sexes; (2) the 5-minute spectral bands (except for the LF/HF ratio), the variation coefficient, expiratory-inspiratory ratio during deep breathing, and the maximum/minimum 30:15 ratio are independent of HR; (3) women up to the age of 55 years have a higher resting HR compared with men; (4) young and middle-aged women show a significantly lower LF power and LF/HF ratio compared with age-matched men, whereas no significant gender differences are observed in the absolute HF power. The authors computed age- and gender-dependent normal values for each of the HRV indices studied here and discuss the clinical consequences arising from gender differences in HRV.

Entities:  

Mesh:

Year:  2001        PMID: 11570610     DOI: 10.1007/bf02322053

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  70 in total

1.  Heart rate variability is altered following spinal cord injury.

Authors:  D C Bunten; A L Warner; S R Brunnemann; J L Segal
Journal:  Clin Auton Res       Date:  1998-12       Impact factor: 4.435

2.  Diurnal heart rate variability in healthy subjects: effects of aging and sex difference.

Authors:  Y Yamasaki; M Kodama; M Matsuhisa; M Kishimoto; H Ozaki; A Tani; N Ueda; Y Ishida; T Kamada
Journal:  Am J Physiol       Date:  1996-07

3.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

Authors:  B M Szabó; D J van Veldhuisen; N van der Veer; J Brouwer; P A De Graeff; H J Crijns
Journal:  Am J Cardiol       Date:  1997-04-01       Impact factor: 2.778

4.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

5.  Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.

Authors:  H Tsuji; F J Venditti; E S Manders; J C Evans; M G Larson; C L Feldman; D Levy
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

6.  Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age.

Authors:  G Sundlöf; B G Wallin
Journal:  J Physiol       Date:  1978-01       Impact factor: 5.182

7.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

8.  Assessment of the primary effect of aging on heart rate variability in humans.

Authors:  C Fukusaki; K Kawakubo; Y Yamamoto
Journal:  Clin Auton Res       Date:  2000-06       Impact factor: 4.435

9.  Spectral analysis of spontaneous heart rate variation in diabetic patients.

Authors:  P Lanting; T J Faes; J J Heimans; B J ten Voorde; J J Nauta; O Rompelman
Journal:  Diabet Med       Date:  1990 Sep-Oct       Impact factor: 4.359

10.  Differential changes of autonomic nervous system function with age in man.

Authors:  M A Pfeifer; C R Weinberg; D Cook; J D Best; A Reenan; J B Halter
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

View more
  65 in total

Review 1.  The riddles of heart rate variability.

Authors:  J M Karemaker
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

2.  Influence of age on linear and nonlinear measures of autonomic cardiovascular modulation.

Authors:  Michael K Boettger; Steffen Schulz; Sandy Berger; Manuel Tancer; Vikram K Yeragani; Andreas Voss; Karl-Jürgen Bär
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

3.  Disparity of autonomic control in type 2 diabetes mellitus.

Authors:  R J Huggett; E M Scott; S G Gilbey; J Bannister; A F Mackintosh; D A S G Mary
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

4.  Acute effects on heart rate variability when exposed to hand transmitted vibration and noise.

Authors:  Bodil Björ; Lage Burström; Marcus Karlsson; Tohr Nilsson; Ulf Näslund; Urban Wiklund
Journal:  Int Arch Occup Environ Health       Date:  2007-06-01       Impact factor: 3.015

5.  Heart rate effects of intraosseous injections using slow and fast rates of anesthetic solution deposition.

Authors:  Louis Susi; Al Reader; John Nusstein; Mike Beck; Joel Weaver; Melissa Drum
Journal:  Anesth Prog       Date:  2008

6.  Cardiac reactivity during the ascending phase of acute intravenous alcohol exposure and association with subjective perceptions of intoxication in social drinkers.

Authors:  Vatsalya Vatsalya; Reza Momenan; Daniel W Hommer; Vijay A Ramchandani
Journal:  Alcohol Clin Exp Res       Date:  2014-03-21       Impact factor: 3.455

7.  Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Authors:  Cheng-Yin Tan; Nortina Shahrizaila; Kee-Ying Yeoh; Khean-Jin Goh; Maw-Pin Tan
Journal:  Clin Auton Res       Date:  2018-04-13       Impact factor: 4.435

8.  Sex differences in heart rate variability: a longitudinal study in international elite cross-country skiers.

Authors:  Daniela Schäfer; Gard Filip Gjerdalen; Erik Ekker Solberg; Maria Khokhlova; Victoria Badtieva; David Herzig; Lukas Daniel Trachsel; Patrik Noack; Laura Karavirta; Prisca Eser; Hugo Saner; Matthias Wilhelm
Journal:  Eur J Appl Physiol       Date:  2015-05-23       Impact factor: 3.078

9.  The role of moxonidine, a second generation centrally acting antihypertensive agent as antihypertensive therapy in the obese.

Authors:  E Karlafti; A Hatzitolios; Ch Savopoulos
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

10.  In Reply.

Authors:  Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2017-01-20       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.